Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology Indian Medical PG Practice Questions and MCQs

Question 221: Regarding dantrolene sodium, which statement is false?

A. Hepatotoxicity is a side effect.
B. It may be given orally.
C. It is supplied mixed with mannitol in ampoules.
D. It increases the release of calcium from the sarcoplasmic reticulum. (Correct Answer)

Explanation: ### Explanation **Mechanism of Action (The Correct Answer)** The statement in Option D is false because Dantrolene **decreases** (inhibits) the release of calcium from the sarcoplasmic reticulum. It acts as a muscle relaxant by binding to the **Ryanodine Receptor 1 (RyR1)** channels on the sarcoplasmic reticulum of skeletal muscle. By blocking these channels, it prevents the release of calcium into the cytosol, thereby decoupling the excitation-contraction process and reducing muscle contraction. **Analysis of Other Options** * **Option A (Hepatotoxicity):** This is a well-known chronic side effect of Dantrolene, especially with long-term oral use. Liver function tests (LFTs) must be monitored. * **Option B (Oral Administration):** Dantrolene can be administered orally for the management of chronic spasticity (e.g., in cerebral palsy or multiple sclerosis). For emergencies like Malignant Hyperthermia, it is given intravenously. * **Option C (Mannitol in Ampoules):** Each vial of intravenous Dantrolene contains a significant amount of **mannitol** (to improve solubility and provide an osmotic diuretic effect to protect the kidneys from myoglobinuria-induced damage). **High-Yield Clinical Pearls for NEET-PG** * **Drug of Choice (DOC):** Dantrolene is the specific antidote and DOC for **Malignant Hyperthermia** and **Neuroleptic Malignant Syndrome (NMS)**. * **Site of Action:** It is a **peripherally acting** skeletal muscle relaxant (unlike diazepam or baclofen, which are centrally acting). * **Malignant Hyperthermia Trigger:** Often triggered by volatile anesthetics (e.g., Halothane) or succinylcholine in genetically predisposed individuals with RyR1 mutations. * **Side Effects:** Muscle weakness, sedation, and potential hepatotoxicity.

Question 222: Which of the following substances develops tolerance the fastest?

A. Cannabis
B. Opioids (Correct Answer)
C. Alcohol
D. Benzodiazepines

Explanation: **Explanation:** The development of tolerance refers to the requirement of higher doses of a drug to achieve the same pharmacological effect. Among the given options, **Opioids** exhibit the most rapid and profound development of tolerance. **1. Why Opioids (Correct):** Opioids (like Morphine and Heroin) induce tolerance through several mechanisms, primarily the **uncoupling of G-protein coupled receptors (GPCRs)** from their second messenger systems and rapid receptor internalization (downregulation). Tolerance to analgesic and euphoric effects develops within days of continuous use. Notably, tolerance to opioids is "differential"—it develops rapidly to analgesia and respiratory depression, but **never** develops to **miosis (pin-point pupils)** and **constipation**. **2. Why other options are incorrect:** * **Cannabis:** While tolerance occurs due to CB1 receptor downregulation, it is generally slower and less clinically dramatic than that of opioids. * **Alcohol:** Tolerance to alcohol involves both metabolic (induction of CYP2E1) and pharmacodynamic (NMDA receptor upregulation) changes, but it typically develops over weeks to months of chronic consumption. * **Benzodiazepines:** Tolerance develops relatively quickly to the sedative and anticonvulsant effects but much more slowly to the anxiolytic effects. It is generally less rapid than opioid tolerance. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Opioid Non-tolerance:** "Miosis and Constipation" (The pupil and the bowel never forget). * **Cross-tolerance:** Exists between drugs of the same class (e.g., between Morphine and Fentanyl) and sometimes between classes (e.g., Alcohol and Benzodiazepines). * **Tachyphylaxis:** This is the term for "acute tolerance" that develops very rapidly (e.g., Ephedrine, Tyramine, Nitrates).

Question 223: Serious, adverse behavioral reactions, including hostility, aggression, and suicidal thoughts and behaviors are associated with which of the following drugs?

A. Pregabalin
B. Topiramate
C. Levetiracetam (Correct Answer)
D. Lamotrigine

Explanation: The correct answer is **Levetiracetam**. **1. Why Levetiracetam is correct:** Levetiracetam is a widely used broad-spectrum antiepileptic drug (AED) that acts by binding to the **SV2A (Synaptic Vesicle Protein 2A)**, modulating neurotransmitter release. While generally well-tolerated due to its minimal drug-drug interactions, its most significant clinical limitation is its **neuropsychiatric side effect profile**. It is notoriously associated with "Levetiracetam-induced rage," characterized by irritability, hostility, aggression, and an increased risk of suicidal ideation. These behavioral changes occur in approximately 10-15% of patients and are a frequent reason for discontinuation. [1] **2. Why the other options are incorrect:** * **Pregabalin:** Primarily associated with sedation, dizziness, peripheral edema, and weight gain. While all AEDs carry a generic FDA warning for suicidal thoughts, it is not a hallmark side effect of Pregabalin. [1] * **Topiramate:** Known for causing **cognitive slowing** ("word-finding difficulties" or "dope-iramate"), metabolic acidosis, and nephrolithiasis. [2] * **Lamotrigine:** Its most serious concern is life-threatening dermatological reactions, specifically **Stevens-Johnson Syndrome (SJS)** and Toxic Epidermal Necrolysis (TEN), especially if titrated too rapidly. [3] **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Levetiracetam is the only AED that binds to SV2A. * **Metabolism:** It is not metabolized by the Cytochrome P450 system (renally excreted), making it the drug of choice for patients on multiple medications (e.g., HIV or transplant patients). [2] * **Contraindication:** Use with caution in patients with pre-existing psychiatric disorders or depression. * **Brivaracetam:** A newer analog of levetiracetam with higher affinity for SV2A and potentially fewer behavioral side effects. [1]

Question 224: Lamotrigine is known to cause which of the following common side effects?

A. Rash (Correct Answer)
B. Irritability
C. Nephrotoxicity
D. Behavioral disturbances

Explanation: **Explanation:** **Lamotrigine** is a broad-spectrum antiepileptic drug (AED) that acts primarily by blocking voltage-gated sodium channels [1], [2] and inhibiting the release of excitatory neurotransmitters like glutamate [1]. **Why "Rash" is correct:** The most significant and characteristic side effect of Lamotrigine is a **maculopapular skin rash**, occurring in approximately 5-10% of patients. While often mild, it can progress to life-threatening hypersensitivity reactions such as **Stevens-Johnson Syndrome (SJS)** or **Toxic Epidermal Necrolysis (TEN)**. The risk is significantly higher if the drug is started at a high dose or escalated too rapidly, which is why a "start low, go slow" titration schedule is mandatory in clinical practice. **Analysis of Incorrect Options:** * **Irritability & Behavioral disturbances:** These are more commonly associated with **Levetiracetam**. While Lamotrigine is generally well-tolerated and even has mood-stabilizing properties (used in Bipolar Disorder), Levetiracetam is notorious for causing "Levy-rage" or behavioral agitation. * **Nephrotoxicity:** Lamotrigine is primarily metabolized by the liver (glucuronidation). It is not typically nephrotoxic. Drugs like Lithium or certain NSAIDs are more frequently associated with renal side effects in a CNS context. **High-Yield Clinical Pearls for NEET-PG:** * **Drug Interaction:** **Valproate** inhibits the metabolism of Lamotrigine, doubling its half-life and significantly increasing the risk of SJS. Conversely, Carbamazepine and Phenytoin decrease Lamotrigine levels. * **Clinical Use:** It is the preferred AED for **pregnancy** (low teratogenic risk) and is highly effective for **Lennox-Gastaut Syndrome** and **Bipolar Depression**. * **Mechanism:** Sodium channel blockade + Inhibition of Glutamate release [1].

Question 225: Which of the following is safest to be used in asthmatic patients?

A. Nitrazepam (Correct Answer)
B. Phenobarbitone
C. Chloral hydrate
D. All hypnotics are safe

Explanation: **Explanation:** The primary concern when prescribing hypnotics to patients with respiratory compromise, such as asthma or COPD, is **respiratory depression**. **1. Why Nitrazepam is the Correct Answer:** Nitrazepam is a **Benzodiazepine (BZD)**. Benzodiazepines are generally preferred in asthmatic patients because they have a high therapeutic index and cause **minimal respiratory depression** at hypnotic doses. They do not significantly affect the hypoxic drive or carbon dioxide response in healthy individuals or those with mild-to-moderate respiratory disease. **2. Why the Other Options are Incorrect:** * **Phenobarbitone:** As a **Barbiturate**, it is a potent respiratory depressant. Barbiturates decrease the sensitivity of the medullary respiratory center to CO2 and can induce laryngospasm. They are strictly avoided in patients with compromised respiratory function. * **Chloral Hydrate:** This is an older non-benzodiazepine sedative. While less potent than barbiturates, it can still cause respiratory depression and is irritating to the gastric mucosa. It is rarely used in modern practice due to its narrow safety margin compared to BZDs. * **All hypnotics are safe:** This is incorrect because the degree of respiratory depression varies significantly across drug classes (BZDs vs. Barbiturates vs. General Anesthetics). **Clinical Pearls for NEET-PG:** * **Drug of Choice for Insomnia:** Z-drugs (Zolpidem, Zopiclone) are currently preferred over BZDs as they have even less effect on sleep architecture and respiratory drive. * **Specific Contraindication:** Avoid Barbiturates in **Porphyria** (due to enzyme induction) and severe **Asthma/COPD**. * **Antidote:** If BZDs cause respiratory depression (usually in overdose or when combined with alcohol), the specific antagonist is **Flumazenil**.

Question 226: Which skeletal muscle relaxant is preferred in patients with liver and renal disease?

A. Atracurium (Correct Answer)
B. Mivacurium
C. Gallamine
D. Vecuronium

Explanation: **Explanation:** The correct answer is **Atracurium** (Option A). **Why Atracurium is preferred:** Atracurium is unique because it does not rely on the liver or kidneys for its elimination. It undergoes **Hofmann elimination**, a spontaneous non-enzymatic degradation in the plasma at physiological pH and temperature. Additionally, it is metabolized by **ester hydrolysis** via non-specific plasma esterases. This makes it the drug of choice for patients with multi-organ failure, particularly renal or hepatic impairment, as its duration of action remains unchanged. **Analysis of Incorrect Options:** * **B. Mivacurium:** While it is metabolized by plasma cholinesterase (like succinylcholine), its duration can be significantly prolonged in patients with liver disease due to decreased synthesis of cholinesterase enzymes. * **C. Gallamine:** This is a long-acting relaxant that is **excreted unchanged entirely by the kidneys**. It is strictly contraindicated in renal failure as it leads to profound cumulative toxicity. * **D. Vecuronium:** This drug is primarily metabolized by the liver and excreted in bile. Its action is significantly prolonged in patients with cirrhosis or hepatic cholestasis. **NEET-PG High-Yield Pearls:** * **Cisatracurium:** An isomer of atracurium, it also undergoes Hofmann elimination but is more potent and produces less **laudanosine** (a metabolite of atracurium that can cause seizures at high levels). It is often preferred over atracurium in ICU settings. * **Rocunorium:** The non-depolarizing blocker with the fastest onset of action, making it an alternative for rapid sequence intubation if succinylcholine is contraindicated. * **Sugammadex:** A specific reversal agent used for the rapid termination of neuromuscular blockade induced by Vecuronium and Rocuronium.

Question 227: Which drug does not cause dependence?

A. LSD (Correct Answer)
B. Cannabis
C. Benzodiazepine
D. Opioids

Explanation: ### Explanation The core concept behind drug dependence is the activation of the **mesolimbic dopaminergic pathway** (the "reward circuit"), which involves dopamine release in the **Nucleus Accumbens** [2]. **1. Why LSD is the correct answer:** LSD (Lysergic acid diethylamide) is a potent hallucinogen that primarily acts as a partial agonist at **5-HT2A receptors** [1], [2]. Unlike opioids or stimulants, hallucinogens do **not** stimulate the mesolimbic dopamine system. Consequently, they do not produce "craving" or compulsive drug-seeking behavior. While users develop rapid **tolerance** (tachyphylaxis), they do not develop physical or psychological dependence or withdrawal symptoms [1]. **2. Why the other options are incorrect:** * **Cannabis:** Acts on **CB1 receptors**, leading to increased dopamine release [4]. Chronic use can lead to "Amotivational Syndrome" and a recognized withdrawal syndrome (irritability, insomnia) [3]. * **Benzodiazepines:** These are positive allosteric modulators of **GABA-A receptors**. Chronic use leads to down-regulation of receptors, resulting in significant physical dependence and potentially life-threatening withdrawal (seizures). * **Opioids:** Act on **$\mu$-opioid receptors**, inhibiting GABAergic interneurons in the VTA, which disinhibits dopamine neurons [2]. They have the highest potential for both physical and psychological dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Drugs with NO dependence:** LSD, Psilocybin, Mescaline (Hallucinogens) [1]. * **Flashbacks (Hallucinogen Persisting Perception Disorder):** A unique long-term side effect of LSD where the user re-experiences the "trip" without taking the drug. * **Tachyphylaxis:** LSD shows rapid tolerance due to 5-HT2A receptor down-regulation [1]. * **Most Addictive Substance:** Nicotine is often cited as having the highest addiction potential, while Opioids have the most severe physical dependence.

Question 228: Which of the following opioids has the maximum plasma protein binding capacity?

A. Morphine
B. Sufentanil (Correct Answer)
C. Fentanyl
D. Pethidine

Explanation: The degree of plasma protein binding (PPB) for opioids is a critical pharmacokinetic parameter that influences their volume of distribution and duration of action [2]. **Why Sufentanil is Correct:** Sufentanil is a highly potent thienyl analogue of fentanyl. It exhibits the **highest plasma protein binding** among commonly used opioids, at approximately **93%**. It primarily binds to **$\alpha_1$-acid glycoprotein**. Despite its high protein binding, it is extremely lipid-soluble, allowing it to cross the blood-brain barrier rapidly, contributing to its high potency (5–10 times more potent than fentanyl) [1]. **Analysis of Incorrect Options:** * **Morphine:** It has the lowest protein binding among the options, at approximately **30–35%**. It is relatively hydrophilic, which results in a slower onset of action compared to synthetic opioids [1]. * **Fentanyl:** While highly lipid-soluble, its plasma protein binding is approximately **80–85%**, which is significantly lower than that of its derivative, sufentanil [1]. * **Pethidine (Meperidine):** It has a moderate protein binding capacity of approximately **60–70%** [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Hierarchy:** Sufentanil > Fentanyl > Remifentanil > Morphine > Pethidine [1]. * **Metabolism:** Most opioids are metabolized in the liver. However, **Remifentanil** is unique as it is metabolized by non-specific plasma and tissue esterases (making it ideal for continuous infusion due to its ultra-short half-life). * **Active Metabolites:** Morphine produces **Morphine-6-glucuronide** (active analgesic) and Morphine-3-glucuronide (neurotoxic). Pethidine produces **Norpethidine**, which can cause seizures in patients with renal failure. * **Mnemonic for PPB:** Remember **"S"** for **S**ufentanil = **S**uperior binding (93%).

Question 229: Ethosuximide is indicated for the treatment of which type of seizure disorder?

A. Generalized tonic-clonic seizures
B. Absence seizures (Correct Answer)
C. Complex partial seizures
D. Myoclonic seizures

Explanation: **Explanation:** **Ethosuximide** is the drug of choice for **Absence seizures (Petit mal)**. The underlying mechanism involves the selective inhibition of **T-type voltage-gated calcium channels** in thalamic neurons. Since the thalamus acts as the pacemaker for the characteristic 3-Hz spike-and-wave discharges seen in absence seizures, blocking these channels effectively suppresses the abnormal electrical activity. **Analysis of Options:** * **Generalized tonic-clonic seizures (GTCS):** Ethosuximide is ineffective here as it does not affect sodium channels or GABAergic transmission. Valproate or Levetiracetam are preferred. * **Complex partial (Focal) seizures:** These require drugs that act on sodium channels (e.g., Carbamazepine, Phenytoin). Ethosuximide has no role in focal epilepsy. * **Myoclonic seizures:** While Valproate is the drug of choice for myoclonic seizures, Ethosuximide is specifically narrow-spectrum and limited to absence seizures. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Ethosuximide is the first-line treatment for pure absence seizures. However, if a patient has **co-existing GTCS and absence seizures**, **Valproate** becomes the drug of choice. * **EEG Finding:** Absence seizures are classically associated with a **3-Hz spike-and-wave pattern**. * **Side Effects:** Remember the mnemonic **EFGH** – **E**thosuximide causes **F**atigue, **G**I distress, **H**eadache (and rarely, Hematologic issues like pancytopenia or Stevens-Johnson Syndrome). * **Pharmacokinetics:** It does not bind to plasma proteins and is metabolized by hepatic enzymes, but it does not induce them.

Question 230: Which of the following is NOT an indication for the use of anticonvulsants?

A. Chronic pain
B. Bipolar disorder
C. Anxiety disorder
D. Diabetic neuropathy (Correct Answer)

Explanation: The question contains a technical error in its premise, as **Diabetic Neuropathy** is a well-established indication for anticonvulsants. However, based on the provided key, here is the educational breakdown: ### **Explanation** Anticonvulsants (Antiepileptic Drugs - AEDs) are increasingly used for non-epileptic conditions due to their ability to stabilize excitable membranes and modulate neurotransmitters like GABA and Glutamate. * **Why Diabetic Neuropathy is the "Correct" Answer (Contextual Analysis):** In standard clinical practice, this is actually a **primary indication**. Drugs like **Pregabalin and Gabapentin** are first-line treatments for diabetic neuropathy. If this appeared in a NEET-PG exam with this key, it would likely be a "controversial" or "recalled" question where the examiner might be looking for a more specific psychiatric vs. neurological distinction, or it may be a distractor. * **Chronic Pain (Option A):** Anticonvulsants are widely used for neuropathic chronic pain. Carbamazepine is the drug of choice for **Trigeminal Neuralgia**. * **Bipolar Disorder (Option B):** Several AEDs act as mood stabilizers. **Valproate** and **Carbamazepine** are used for acute mania, while **Lamotrigine** is used for maintenance to prevent depressive episodes. * **Anxiety Disorder (Option C):** Certain AEDs are indicated here; for example, **Pregabalin** is approved for Generalized Anxiety Disorder (GAD). ### **High-Yield Clinical Pearls for NEET-PG** * **Drug of Choice (DOC) for Trigeminal Neuralgia:** Carbamazepine. * **DOC for Absence Seizures:** Ethosuximide (Valproate if generalized tonic-clonic seizures are also present). * **Teratogenicity:** Valproate is associated with Neural Tube Defects (highest risk among AEDs). * **SJS/TEN Risk:** Lamotrigine and Carbamazepine (especially in patients with HLA-B*1502 allele). * **Weight Gain:** Common with Valproate; **Weight Loss** is common with Topiramate and Zonisamide.

Practice by Chapter

General Anesthetics

Practice Questions

Local Anesthetics

Practice Questions

Sedative-Hypnotics

Practice Questions

Antiepileptic Drugs

Practice Questions

Antiparkinsonian Drugs

Practice Questions

Opioid Analgesics

Practice Questions

Drugs of Abuse and Addiction

Practice Questions

Psychostimulants

Practice Questions

Hallucinogens

Practice Questions

CNS Stimulants and Cognitive Enhancers

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free